Search - tctmd.com

Displaying 501 - 520 of 785

Sort: Relevancy | Date

News Industry News

First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and OrbusNeich’s clinical program

July 16, 2014

News Industry News

OrbusNeich Announces First Patient Enrollment in Physician-Initiated Study to Evaluate the Potential for Shorter-Term Dual Antiplatelet Therapy in ACS Patients

June 19, 2014

News Industry News

STENTYS to Acquire Stent Delivery Technology for Its Next-Generation of Self-Apposing Stents

June 04, 2014

News Industry News

Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study

May 29, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Industry News

STENTYS Self-Apposing Stent Featured Prominently at 2014 EuroPCR Conference

May 27, 2014

News Industry News

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patient

May 20, 2014

News Daily News

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

May 20, 2014

News Daily News

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

May 20, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

News Conference News EuroPCR 2014

APPOSITION IV: Self-Expanding SES Covers Struts Better, Faster than Balloon-Expandable DES

Yael L. Maxwell

May 20, 2014

News Industry News

Micell Technologies Announces Clinical Data from MiStent SES Studies Will Be Presented at EuroPCR 2014

May 15, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

Presentation CIT 2014

XIENCE V China RCT 2 Year Results:A Prospective, Multi-center Randomized Trial Assessing the Safety and Effectiveness of XIENCE V Everolimus-Eluting Stent Compared to CYPHER Sirolimus-Eluting Stent

Presenter: Gao Runlin

March 22, 2014

Presentation CIT 2014

Optical coherence tomography assessment of a PLGA-polymer with electro-grafting base layer versus a PLA-polymer sirolimus-eluting stents at 3 months follow-up: The BuMA-OCT Randomized Trial

Presenter: Yao-Jun Zhang

March 22, 2014

Presentation CIT 2014

CREDIT I: A First-In-Man Study of the Second Generation EXCEL Biodegradable PolymerSirolimus-Eluting Stent - 4-Month Clinical, Angiographic, and OCT Results

Presenter: Han Yaling

March 22, 2014

Presentation CIT 2014

A Prospective, Multicenter, Randomized Trial of YINYI Polymer-Free Paclitaxel-Eluting Stent vs. Durable Polymer Sirolimus-Eluting Stent in the Treatment of Coronary Artery Disease

Presenter: Yong Huo

March 22, 2014

News Daily News

Readmissions Higher with PCI vs CABG for Left Main Disease

March 14, 2014

News Daily News

Más Rehospitalizaciones con PCI frente a CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo

March 14, 2014

News Daily News

Resultados a Largo Plazo Similares para CABG y SLF en Mujeres con Enfermedad de Tronco Coronario Izdo

February 26, 2014

Advertisement

First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and OrbusNeich’s clinical program

OrbusNeich Announces First Patient Enrollment in Physician-Initiated Study to Evaluate the Potential for Shorter-Term Dual Antiplatelet Therapy in ACS Patients

STENTYS to Acquire Stent Delivery Technology for Its Next-Generation of Self-Apposing Stents

Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

STENTYS Self-Apposing Stent Featured Prominently at 2014 EuroPCR Conference

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patient

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

APPOSITION IV: Self-Expanding SES Covers Struts Better, Faster than Balloon-Expandable DES

Micell Technologies Announces Clinical Data from MiStent SES Studies Will Be Presented at EuroPCR 2014

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

XIENCE V China RCT 2 Year Results:A Prospective, Multi-center Randomized Trial Assessing the Safety and Effectiveness of XIENCE V Everolimus-Eluting Stent Compared to CYPHER Sirolimus-Eluting Stent

Optical coherence tomography assessment of a PLGA-polymer with electro-grafting base layer versus a PLA-polymer sirolimus-eluting stents at 3 months follow-up: The BuMA-OCT Randomized Trial

CREDIT I: A First-In-Man Study of the Second Generation EXCEL Biodegradable PolymerSirolimus-Eluting Stent - 4-Month Clinical, Angiographic, and OCT Results

A Prospective, Multicenter, Randomized Trial of YINYI Polymer-Free Paclitaxel-Eluting Stent vs. Durable Polymer Sirolimus-Eluting Stent in the Treatment of Coronary Artery Disease

Readmissions Higher with PCI vs CABG for Left Main Disease

Más Rehospitalizaciones con PCI frente a CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo

Resultados a Largo Plazo Similares para CABG y SLF en Mujeres con Enfermedad de Tronco Coronario Izdo

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content